Skip to contentS
Strata Critical Medical, Inc.
S
SRTAStrata Critical Medical, Inc. Q1 2023 · 10-Q
Revenue$45.27M$45.27M+70.0% vs Q1 2022 Net Income-$10.19M-$10.19MN/M vs Q1 2022 EPS Diluted-$0.14-$0.14N/M vs Q1 2022 Gross Profit$7,164,000+145.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Strata Critical Medical, Inc. · CIK 1779128 · Engraved from SEC EDGAR
Operating Cash Flow-$16,855,000N/M Free Cash Flowderived-$17,501,000N/M Margins · derivedGross margin15.8%+4.8 pt vs Q1 2022
Operating margin-28.3%+23.1 pt vs Q1 2022
Net margin-22.5%+18.8 pt vs Q1 2022
ended Mar 31, 2023 · filed May 11, 2023 · 41 d after period end